News

18 Gustave Roussy doctors and researchers named among the world’s most influential researchers in 2026

The 2026 Highly Cited Researchers list, published by Clarivate, recognises 18 doctors and researchers affiliated with Gustave Roussy. This international recognition reflects the influence of the research conducted at the Institute and its impact across the global scientific community.

Published on

Illsutration abstraite Highly Cited Researchers

Each year, the Highly Cited Researchers list identifies scientists whose work has had a significant and far-reaching influence in their field of research. In 2026, 6,802 researchers from more than 1,200 institutions across 62 countries and regions were recognised, accounting for 7,090 awards. France received 121 awards, ranking 10th worldwide and accounting for 1.7% of the total.

Eighteen doctors and researchers from Gustave Roussy and Gustave Roussy Foundation, who currently work there or conducted their research there during the period considered for this selection, feature in the 2026 Highly Cited Researchers list:

“The inclusion of 18 Gustave Roussy doctors and researchers among the Highly Cited Researchers 2026 reflects the international excellence and influence of the research conducted at Gustave Roussy, as well as its contribution to scientific advances with a societal impact in oncology. This distinction also recognises the collective commitment of all Gustave Roussy teams, whose work every day drives this scientific momentum and enables high-level research for the benefit of people living with cancer,” says Professor Fabrice Barlesi, Chief Executive Officer of Gustave Roussy.

One researcher in 1,000 worldwide is included in the Highly Cited Researchers list

The Highly Cited Researchers list represents approximately one researcher in 1,000 across the global scientific community.

The inclusion of 18 Gustave Roussy doctors and researchers in the 2026 edition therefore illustrates the strong international visibility of the research conducted at the Institute and its contribution to scientific advances in oncology.

A selection based on the influence of scientific publications

The selection is not based simply on citation counts. It draws on data from the Web of Science Core Collection and identifies researchers who have published several Highly Cited Papers, meaning papers that rank among the top 1% most cited publications in their field and year of publication. For the 2026 edition, Clarivate analysed publications over ten years, from 2015 to 2025.

This quantitative analysis is complemented by qualitative assessment and the expertise of Clarivate analysts. The methodology also places considerable emphasis on research integrity, using filters designed to detect exceptionally high publication volumes, excessive self-citation, and unusual publication or citation patterns.

The Highly Cited Researchers list is therefore not simply a ranking based on citation counts. It seeks to identify scientists whose work has had a significant and far-reaching influence across the international scientific community.

Find out more: read about the Highly Cited Researchers selection methodology on the Clarivate website.

Last news

  • Two photon-counting CT scanners now equip Gustave Roussy's imaging department

    Since September 2026, Gustave Roussy's Department of Medical Imaging has been equipped with a second photon-counting CT scanner, delivering higher image resolution while reducing the doses of X-rays and contrast agent administered to patients. This technology recently enabled the Institute to perform an iodine-free pulmonary CT angiogram, a world first.

    Photographie du scanner à comptage photonique
  • Prevention and screening: getting ahead of lung cancer

    To mark Thoracic Cancer Awareness Month and Tobacco-Free Month, two campaigns focusing on lung cancer, Gustave Roussy highlights its initiatives to advance prevention and screening among people at increased risk. Since its creation in 2021, the Institute’s Interception Lung programme has welcomed more than 900 participants, supporting them to stop smoking and offering personalised screening for the disease.

    Photographie : patient effectuant un scanner thoracique et équipes soignantes
  • Gustave Roussy Meets His Audience

    As part of its awareness-raising and fundraising efforts, Gustave Roussy is currently conducting a door-to-door outreach campaign in several towns in Val-de-Marne (Fresnes, Vitry-sur-Seine, Nogent-sur-Marne, Bry-sur-Marne, Le Kremlin-Bicêtre) from Monday through Saturday, 1:30 p.m. to 8:00 p.m.

    Deux personnes en charge de la collecte porte-à-porte
  • Mens November: Take care of your jewelry its precious!

    November is the month dedicated to raising awareness and promoting prevention of male cancers, which include prostate, testicular, and penile cancers. The goal is to raise public awareness of these diseases—which account for approximately 63,000 new cases in France each year—and to encourage men to perform testicular self-exams, a simple step that can help detect a lump, the nature of which must then be determined through further medical examinations. Gustave Roussy has extensive expertise in the treatment of male cancers, particularly through its Genitourinary Oncology Committee, which is deeply involved in research on these diseases. 

    Visuel fixe campagne novembre masculin